Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-24

FDA Approved: ERLOTINIB — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Camber Pharmaceuticals' original application for Erlotinib (ERLOTINIB), enabling a generic version of the cancer drug to be marketed in the Uni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ERLOTINIB (Erlotinib)

Snippet

ORIG AP for ERLOTINIB (ERLOTINIB)